GUILING YANG: Open Payments
NPI 1891033387 · DURHAM, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$997 in 8 payments from 8 companies in 2025. Trend: 2023 $125 · 2024 $215 · 2025 $997
Food & beverage: $997
| Company | Payments | Amount |
|---|---|---|
| Sequel Med Tech, LLC | 1 | $202 |
| CeQur Corporation | 1 | $186 |
| BETA BIONICS, INC. | 1 | $172 |
| Ascensia Diabetes Care Us Inc. | 1 | $113 |
| Lilly USA, LLC | 1 | $109 |
| SANOFI-AVENTIS U.S. LLC | 1 | $91 |
| Novo Nordisk Inc | 1 | $82 |
| Amgen Inc. | 1 | $41 |
Products named: TWIIST, CeQur Simplicity, iLet Bionic Pancreas, TZIELD, Wegovy, REPATHA.
Industry payments across NC — which companies pay providers there.
